In the world of pharmaceutical innovation, there’s a quiet revolution happening behind the scenes. While most eyes are on flashy new drug launches, a less visible but incredibly powerful industry is making those breakthroughs possible—contract development and manufacturing organizations, or CDMOs. More specifically, those specializing in peptides and oligonucleotides are stealing...